Optimizing hormone therapy for future reproductive performance in women with premature ovarian failure

References

• Coulam CB, Adamson SC, Anegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604–606.
   PubMed Web of Science ®Google Scholar
• Falsetti L, Scalchi S, Villani MT, Bugari G. Premature ovarian failure. Gynecol Endocrinol 1999;13:189–195.
   PubMed Web of Science ®Google Scholar
• Rebar RW, Connolly HV. Clinical features of young women with hypergonadotrophic amenorrhea. Fertil Steril 1990;53:804–810.
   PubMed Web of Science ®Google Scholar
• Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HS. Characterization of idiopathic premature ovarian failure. Fertil Steril 1996;65:337–341.
   PubMed Web of Science ®Google Scholar
• Tibiletti MG, Testa G, Vegetti W, Alagna F, Crosignani PG. The idiopathic forms of premature menopause and early menopause show the same genetic pattern. Hum Reprod 1999;14:2731–2734.
   PubMed Web of Science ®Google Scholar
• Chakravati S, Collins WP, Forecast JD, Newton JR, Orarn DH, Studd JW. Hormone profile after the menopause. Br Med J 1976;2:784–786.
   Google Scholar
• Alzubaidi NH, Chapin HL, Vanderhoof VH, Calis KA, Nelson LM. Meting the needs of young women with secondary amenorrhea and spontaneous premature ovarian failure. Obstet Gynecol 2002;99:720–725.
   PubMed Web of Science ®Google Scholar
• Nelson LM, Anasti JN, Kimzey LM, Defensor RA, Lipetz KJ, White BJ, Shawker TH, Merino MJ. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 1994;79:1470–1475.
   PubMed Web of Science ®Google Scholar
• Jequier AM, Davis SR. The premature menopause: an example of a difficult diagnostic problem. In Programs and Abstracts of the 1st Australasian Menopause Society Congress, Perth, Australia; 1997.
   Google Scholar
• Kreiner D, Droesch K, Navot D, Scott R, Rosenwaks Z. Spontaneous and pharmacologically induced remissions in patients with premature ovarian failure. Obstet Gynecol 1988;73:926–928.
   Google Scholar
• van-Kasteren YM, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 1999;5:483–492.
   Google Scholar
• Haber HP, Ranke MB. Pelvic ultrasonography in Turner's syndrome: standards for uterine and ovarian volume. J Ultrasound Med 1999;18:271–276.
   PubMed Web of Science ®Google Scholar
• McDonnell CM, Coleman L, Zacharin RM. A 3-year prospective study to assess uterine growth in girls with Turner's syndrome by pelvic ultrasound. Clin Endocrinol 2003;58:446–450.
   PubMed Web of Science ®Google Scholar
• Kiess W, Conway G, Ritzen M, Rosenfield R, Bernasconi S, Juul A, van Pareren Y, de Muinck Keizer-Schrama SM, Bourguignon JP. Induction of puberty in the hypogonadal girl-practices and attitudes of pediatric endocrinologists in Europe. Horm Res 2002;57:66–71.
   Google Scholar
• Hindmarsh PC. How to you initiate oestrogen therapy in a girl who has not undergone puberty? Clini Endocrinol 2009;71:7–10.
   Google Scholar
• Chernausek SD, Attie KM, Cara JF, Rosenfeld RG, Frane J. Growth hormone therapy of Turners syndrome: the impact of age of estrogen replacement on final height. J Clin Endocrinol Metab 2000;85:2439–2445.
   Google Scholar
• Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, Hintz R, Hovatta O, Hultcrantz M, Landin-Wilhelmsen K, Lin A, Lippe B, et al Recommendations for diagnosis and management of Turners syndrome. J Clin Endocrinol Metab 2001;86:3061–3069.
   PubMed Web of Science ®Google Scholar
• Bannink EM, van Sassen C, van Buuren S, de Jong FH, Lequin M, Mulder PG, de Muinck Keizer-Schrama SM. Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels. Clin Endocrinol 2009;70:265–273.
   PubMed Web of Science ®Google Scholar
• van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Stokvis-Brantsma WH, Rouwé CW, et al Final height in girls with turner syndrome after term growth hormone treatment in three dosages and low dose oestrogens. J Clin Endocrinol Metab 2003;88:1119–1125.
   PubMed Web of Science ®Google Scholar
• Reiter EO, Blethen SL, Baptista J, Price L. Early initiation of growth hormone treatment allows age appropriate estrogen use in Turners syndrome. J Clin Endocrinol Metab 2001;86:1936–1941.
   Google Scholar
• Rosenfield RL, Devine N, Hunold JJ, Mauras N, Moshang T Jr, Root AW. Salutary effects of combining early very low dose systemic oestradiol with growth hormone therapy in girls with Turners syndrome. J Clin Endocrinol Metab 2005;90:6424–6430.
   PubMed Web of Science ®Google Scholar
• Zhang L, Rees MC, Bicknelle R. The isolation and long-term culture of normal human endometrial epithelium and stroma. Expression of mRNAs for angiogenic polypeptides basally and on oestrogen and progesterone challenges. J Cell Sci 1995;108:323–331.
   PubMed Web of Science ®Google Scholar
• Abdalla HI, Brooks AA, Johnson MR, Kirkland A, Thomas A, Studd JWW. Endometrial thickness: a predictor of implantation in ovum recipients. Hum Reprod 1994;9:363–365.
   PubMed Web of Science ®Google Scholar
• Lippe B. Turner's syndrome. Endocrinol Metab Clin North Am 1991;20:121–152.
   PubMed Web of Science ®Google Scholar
• Khastgir G, Abdalla H, Thomas A, Korea L, Latarche L, Studd J. Oocyte donation in Turners syndrome: an analysis of factors affecting the outcome. Hum Reprod 1997;12:279–285.
   PubMed Web of Science ®Google Scholar
• Yaron Y, Ochshorn Y, Amit A, Yovel I, Kogosowski A, Lessing JB. Patients with Turners syndrome may have an inherent endometrial abnormality affecting receptivity in oocyte donation. Fertil Steril 1996;65:1249–1252.
   PubMed Web of Science ®Google Scholar
• Li TC, Dockery P, Ramsewak SS, Klentzeris L, Lenton EA, Cooke ID. The variation of endometrial response to a standard hormone replacement therapy in women with premature ovarian failure. An ultasonographic and histological study. BJOG 1991;98:656–661.
   Google Scholar
• Doerr HG, Bettendorf M, Hauffa BP, Mehls O, Partsch CJ, Said E, Sander S, Schwarz HP, Stahnke N, Steinkamp H, et al Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: results of the German IGLU Follow-up Study 2001. Hum Reprod 2005;20:1418–1421.
   PubMed Web of Science ®Google Scholar
• Snajderova M, Mardesic T, Lebl J, Gerzova, Teslik L, Zapletalova. The uterine length in women with Turners Syndrome reflects the post menarcheal daily estrogen dose. Horm Res 2003;60:198–204.
   PubMedGoogle Scholar
• Paterson WF, Hollman AS, Donaldson DC. Poor uterine development in Turner syndrome with oral oestrogen therapy. Clin Endocrinol 2002;56:359–365.
   PubMed Web of Science ®Google Scholar
• Bakalov VK, Shawker T, Ceniceros I, Bondy CA. Uterine development in Turner Syndrome. J Pediatr 2007;151:528–531.
   PubMed Web of Science ®Google Scholar
• Piippo S, Lenko H, Kainulainen P, Sipilä I. Use of percutaneous estrogen gel for induction of puberty in girls with Turner syndrome. J Clin Endocrinol Metab 2004;89:3241–3247.
   PubMedGoogle Scholar
• Nabhan ZM, Dimeglio LA, Qi R, Perkins SM, Eugster EA. Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study. J Clin Endocrinol Metab 2009;94:2009–2014.
   PubMed Web of Science ®Google Scholar
• Bath LE, Critchley HOD, Chambers SE, Anderson RA, Kelnar CJH, Wallace WHB. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. BJOG 1999;106:1265–1272.
   Web of Science ®Google Scholar
• Larsen EC, Schmiegelow K. Radiotherapy at a young reduces uterine volume of childhood cancer survivors. Acta Obstet Gynecol Scand 2004;83:96–102.
   PubMed Web of Science ®Google Scholar
• Critchley HOD, Wallace WHB, Shalet SM, Mamtora H, Higginson J, Anderson DC. Abdominal irradiation in childhood; the potential for pregnancy. BJOG 1992;99:392–394.
   Web of Science ®Google Scholar
• Smith RA, Hawkins MM. Pregnancies after childhood cancer. Br J Obstet Gynecol 1989;96:378–390.
   PubMedGoogle Scholar
• Merz E, Miric-Tesanic D, Bahlmann F, Wellek S. Sonographic size of uterus and ovaries in pre and postmenopausal women. Ultrasound Obstet Gynecol 1996;7:38–42.
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Arangio S, Draetta FP, Angiolucci M, Volpe A, Melis GB. Transdermal administration of oestradiol and norethisterone: effect on the uterus and uterine arteries. Menopause 2000;7:117–122.
   Google Scholar
• Li TC, Cooke ID, Warren MA, Goolamallee, Graham RA, Aplin JD. Endometrial response in artificial cycles: a prospective study comparing four different oestrogen dosages. BJOG 1992;99:751–756.
   Google Scholar
• Critchley HOD, Buckley HC, Anderson DC. Experience with a physiological steroid replacement regimen for the establishment of a receptive endometrium in women with premature ovarian failure. BJOG 1990;97:804–810.
   Google Scholar
• Press F, Shapiro HM, Cowell CA, Oliver GD. Outcome of ovum donation in Turners syndrome patients. Fertil Steril 1995;64:995–998.
   PubMed Web of Science ®Google Scholar
• Fatemi HM, Bourgain C, Donoso P, Blockeel C, Papanikolaou EG, Popovic-Todorovic B, Devroey P. Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept. Hum Reprod 2007;22:1260–1263.
   PubMed Web of Science ®Google Scholar
• Dallenbach-Hellweg G. The endometrium of infertility. A review. Pathol Res Pract 1984;178:527–538.
   Google Scholar
• Jones GS. Luteal phase defect: a review of pathophysiology. Curr Opin Obstet Gynecol 1991;141:1123–1129.
   Google Scholar
• Nardo LG, Sallam HN. Progesterone supplementation to prevent recurrent miscarriage and to reduce implantation failure in assisted reproductive cycles. Reprod Biomed Online 2006;13:47–57.
   PubMed Web of Science ®Google Scholar
• Guttmann H, Weiner Z, Nikolski E, Ish-Shalom S, Itskovitz-Eldor J, Aviram M, Reisner S, Hochberg Z. Choosing an oestrogen replacement therapy in young adult women with Turner syndrome. Clin Endocrinol 2001;54:159–164.
   PubMed Web of Science ®Google Scholar
• Letur-Konirsch H, Delanian S. Successful pregnancies after combined pentoxifylline-tocopherol treatment in women with premature ovarian failure who are resistant to hormone replacement therapy. Fertil Steril 2002;77:1219–1226.
   PubMed Web of Science ®Google Scholar
• Novat D, Laufer N, Kopolovic J, et al Artificially induced endometrial cycles and establishment of pregnancies in the absence of ovaries. N Engl J Med 1986;314:806–811.
   Google Scholar
• Drobac S, Rubin K, Ragol AD, Rosenfield RL. A workshop on puberty hormone replacement options in United States. J Pediatr Endocrinol Metab 2006;19:55–64.
   PubMed Web of Science ®Google Scholar
• Leung KC, Johansson G, Leong GM, Ho KK. Estrogen regulation of growth hormone action. Endocr Rev 2004;25:693–721.
   PubMed Web of Science ®Google Scholar
• Aarskog D. Maternal progestins as a possible cause of hypospadias. N Engl J Med 1979;300:75–78.
   PubMed Web of Science ®Google Scholar
• Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004;10:251–266.
   PubMed Web of Science ®Google Scholar
• Maruta A, Matsuzaki M, Miyashita H, Kodama F, Kato H, Taguchi J, Tomita N, Sakai R, Fujisawa S, Okubo T, et al Successful pregnancy after allogeneic bone marrow transplantation following conditioning with total body irradiation. Bone Marrow Transplant 1995;15:637–638.
   Google Scholar
• Green JM, Kafetsios K, Statham HE, Snowdon CM. Factor structure, validity and reliability of the Cambridge Worry Scale in a pregnant population. J Health Psychol 2003;8:753–764.
   PubMed Web of Science ®Google Scholar
• Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009;360:606–614.
   PubMed Web of Science ®Google Scholar
• Taylor AE. Systemic adversities of ovarian failure. J Soc Gynecol Investig 2001;8:S7–S9.
   Google Scholar
• Vita JA, Keany JF Jr. Hormone replacement therapy and endothelial function. The exception that proves the rule? Arterioscler Thromb Vasc Biol 2001;21:1867–1869.
   PubMed Web of Science ®Google Scholar
• van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet 1996;347:714–718.
   PubMed Web of Science ®Google Scholar
• De Kleijn MJ, van der Schouw YT, Verbeek AL, Peeters PH, Banga JD, van der Graaf Y. Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol 2002;155:339–345.
   PubMed Web of Science ®Google Scholar
• Jacobsen BK, Heuch I, Kvåle G. Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol 2003;157:923–929.
   PubMed Web of Science ®Google Scholar
• van Der Voort DJ, van Der Weijer PH, Barentsen R. Early menopause: increased fracture risk at older age. Osteoporos Int 2003;14:525–530.
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465–1477.
   PubMed Web of Science ®Google Scholar
• Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, et al Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002;288:49–57.
   PubMed Web of Science ®Google Scholar
• Hendrix SL, Wassertheil-Smoller S, Johnson KC, Howard BV, Kooperberg C, Rossouw JE, Trevisan M, Aragaki A, Baird AE, Bray PF, et al Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation 2006;113:2425–2434.
   PubMed Web of Science ®Google Scholar
• Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE, et al Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003;289:2673–2684.
   PubMed Web of Science ®Google Scholar
• Peverill RE. Hormone therapy and venous thromboembolism. Best Pract Res Clin Endocrinol Metab 2003;17:149–164.
   PubMed Web of Science ®Google Scholar
• Scarabin PY, Oger E, Plu-Bureau G. Estrogen and Thromboembolism Risk Study Group. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 2003;362:428–432.
   PubMed Web of Science ®Google Scholar
• Beral V, Bull D, Reves G, Million Women Study Collaborators. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 2005;365:1543–1551.
   PubMed Web of Science ®Google Scholar
• Shah NR, Borenstein J, Dubois RW. Postmenopausal hormone therapy and breast cancer: a systematic review and meta-analysis. Menopause 2005;12:668–678.
   PubMed Web of Science ®Google Scholar
• Beral V, Million women Study collaborators, Bull D, Reeves G. Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 2007;369:1703–1710.
   PubMed Web of Science ®Google Scholar
• MHRA [internet]. Hormone replacement therapy: update advice. Drug safety update. 2007. Electronic citation. http://www.mhra.gov.uk/Publications/Safetyguidance/DrugSafetyUpdate/CON2032234. Last accesses 18 January 2010.
   Google Scholar